IMAGING CHARACTERISTICS AND SOME RELATED FACTORS OF CEREBRAL LOBE HEMORRHAGE AT THE NEUROLOGY CENTER OF BACH MAI HOSPITAL

Thị Tình Trần, Đăng Thục Ngô, Thế Anh Nguyễn

Main Article Content

Abstract

Objective: Describe the imaging characteristics and some related factors of cerebral lobe hemorrhage at Bach Mai Hospital in 2023-2024. Subjects: 89 patients diagnosed with cerebral lobe hemorrhage were hospitalized at the Neurology Center, Bach Mai Hospital from September 2023 to July 2024. Methods: Cross-sectional descriptive study. Results: The results of the study of 89 patients showed that the rate of patients with interlobar hemorrhage was the highest (49.5%). Regarding the location of bleeding in 1 lobe, the highest rate was bleeding in the frontal lobe (25.8%). The majority of patients had an average size and volume of hematoma. The results of diagnostic imaging showed that (22.5%) had an abnormal cause and (77.5%) showed no abnormality detected. There was evidence of a difference in diagnostic imaging results between the two age groups ≥ 50 years old and under 50 years old (p < 0.05). Among patients ≥ 50 years old with cerebral lobar hemorrhage and examined with brain magnetic resonance imaging (MRI), 35% had images of cerebral amyloid angiopathy (CAA). In the study of 89 patients with cerebral hemorrhage, (10.1%) of the patients had a blood clotting disorder. The medical history of the patients with hypertension was the highest (51.7%). Then, the second row was the risk factors of drinking alcohol and smoking. The study of BMI of patients with cerebral hemorrhage showed that the majority of patients had normal BMI (84.3%). Conclusion: In our study, 22.5% had abnormal imaging results and 35% of brain MRI showed CAA in patients with lobar hemorrhage ≥ 50 years old. History of hypertension, alcohol consumption and smoking were prominent in patients with lobar hemorrhage. In addition, there was a number of patients with concomitant coagulation disorders accounting for 10.1%.

Article Details

References

1. Weber SA, Patel RK, Lutsep HL. Cerebral amyloid angiopathy: diagnosis and potential therapies. Expert Rev Neurother. 2018 Jun; 18(6):503–13.
2. Yamada M. Cerebral amyloid angiopathy: emerging concepts. J Stroke. 2015 Jan;17(1):17–30.
3. Saito S, Tanaka M, Satoh-Asahara N, Carare RO, Ihara M. Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy. Front Pharmacol. 2021;12: 643357.
4. Phạm Thị Thúy. Nghiên cứu đặc điểm lâm sàng, hình ảnh học của chảy máu thùy não ở bệnh nhân dưới 50 tuổi. 2011.
5. Charidimou A, Boulouis G, Frosch MP, Baron JC, Pasi M, Albucher JF, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol. 2022 Aug;21(8):714–25.
6. Itoh Y, Yamada M. Cerebral amyloid angiopathy in the elderly: the clinicopathological features, pathogenesis, and risk factors. J Med Dent Sci. 1997 Mar;44(1):11–9.